Prognia
Drug Database
🇺🇸US · FDA ApprovedNone (Tentative Approval)ANDA090309-001

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE(ABACAVIR SULFATE)

Manufacturer: MYLAN PHARMA

FDA Approval: 15/07/2009

Route: ORAL · TABLET

Active Ingredients

ABACAVIR SULFATE EQ 300MG BASE; LAMIVUDINE 150MG; ZIDOVUDINE 300MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.